Premium
Detection and clinical course of choroidal neovascularization in central serous chorioretinopathy
Author(s) -
Kim Raeyoung,
Park YoungHoon
Publication year - 2021
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.0149
Subject(s) - medicine , choroidal neovascularization , serous fluid , ophthalmology , fluorescein angiography , visual acuity , choroid , indocyanine green , indocyanine green angiography , surgery , retina , physics , optics
Purpose The objective of this study was to observe the detection of choroidal neovascularization (CNV) after central serous chorioretinopathy (CSC) diagnosis and to determine whether clinical features and prognosis differ in CNV eyes from chronic CSC after CNV detection. Methods The medical records of 30 eyes of 30 patients with CSC were retrospectively analyzed in this study. The presence of CNV was diagnosed using fluorescein angiography (FA), indocyanine green angiography (ICGA), or optical coherent tomography angiography (OCTA). The time of initial symptom diagnosis and the period from the diagnosis of CSC to the detection of CNV were estimated based on the medical records. We observed the clinical change pattern by measuring the best‐corrected visual acuity (BCVA), central macular thickness (CMT), and subfoveal choroidal thickness (SFCT) for one year since the detection of CNV. Results The average period until CNV detection was 24.18 ± 29.43 months (mean ± standard deviation) from the initial symptom initiation and 20.10 ± 28.49 months from the first diagnosis of CSC. The CMT significantly decreased in patients with CSC in the one‐year follow‐up after CNV detection (p = 0.01), but no statistically significant changes were found in BCVA and SFCT. Conclusions In CSC patients, CNV detection was observed earlier than previously reported, and after CNV detection, there was no rapid deterioration of visual acuity or clinical features.